Cargando…

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

INTRODUCTION: Frequent assessments of rheumatoid arthritis (RA) disease activity allow timely adaptation of therapy, which is essential in preventing disease progression. However, values of acute phase reactants (APRs) are needed to calculate current composite activity indices, such as the Disease A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aletaha, Daniel, Nell, Valerie PK, Stamm, Tanja, Uffmann, Martin, Pflugbeil, Stephan, Machold, Klaus, Smolen, Josef S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175030/ https://www.ncbi.nlm.nih.gov/pubmed/15987481 http://dx.doi.org/10.1186/ar1740

Ejemplares similares

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?
por: Machold, Klaus P, et al.
Publicado: (2006)

Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure
por: Kapral, Theresa, et al.
Publicado: (2006)

Remission by composite scores in rheumatoid arthritis: are ankles and feet important?
por: Kapral, Theresa, et al.
Publicado: (2007)

Value of self-performed joint counts in rheumatoid arthritis patients near remission
por: Radner, Helga, et al.
Publicado: (2012)

Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials
por: Aletaha, Daniel, et al.
Publicado: (2015)

Developments in the clinical understanding of rheumatoid arthritis
por: Smolen, Josef S, et al.
Publicado: (2009)

Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs
por: Radner, Helga, et al.
Publicado: (2014)

Doubtful swelling on clinical examination reflects synovitis in rheumatoid arthritis
por: Mandl, Peter, et al.
Publicado: (2020)

Autoantibodies in very early rheumatoid arthritis: diagnostic tools or pathogenic players?
por: Steiner, G, et al.
Publicado: (2003)

American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision
por: Studenic, Paul, et al.
Publicado: (2023)

American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision
por: Studenic, Paul, et al.
Publicado: (2022)

The diagnostic significance of autoantibodies in patients with very early rheumatoid arthritis
por: Nell, V, et al.
Publicado: (2003)

Clinical joint inactivity predicts structural stability in patients with established rheumatoid arthritis
por: Gärtner, M, et al.
Publicado: (2016)

Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort
por: Biliavska, Iuliia, et al.
Publicado: (2013)

Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients
por: Radner, Helga, et al.
Publicado: (2015)

Circulating Cytokine Profiles and Their Relationships with Autoantibodies, Acute Phase Reactants, and Disease Activity in Patients with Rheumatoid Arthritis
por: Meyer, Pieter W. A., et al.
Publicado: (2010)

Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis
por: Lopez-Romero, Pedro, et al.
Publicado: (2022)

Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year
por: Kay, Jonathan, et al.
Publicado: (2014)

The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?
por: Smolen, Josef S, et al.
Publicado: (2008)

Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials
por: Smolen, Josef, et al.
Publicado: (2019)

Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction
por: Smolen, Josef S, et al.
Publicado: (2011)

Patient education, disease activity and physical function: can we be more targeted? A cross sectional study among people with rheumatoid arthritis, psoriatic arthritis and hand osteoarthritis
por: Drăgoi, Răzvan G, et al.
Publicado: (2013)

Analysis of gene expression in rheumatoid arthritis and related conditions offers insights into sex-bias, gene biotypes and co-expression patterns
por: Platzer, Alexander, et al.
Publicado: (2019)

The science of rheumatoid arthritis: a prelude
por: Smolen, Josef S
Publicado: (2005)

Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria
por: Smolen, Josef S., et al.
Publicado: (2017)

Therapeutic implications of autoantibodies in rheumatoid arthritis
por: Aletaha, Daniel, et al.
Publicado: (2016)

Azilsartan as “Add-On” Treatment with Methotrexate Improves the Disease Activity of Rheumatoid Arthritis
por: Mahmood, Naza Mohammed Ali, et al.
Publicado: (2018)

Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition
por: Schoels, M., et al.
Publicado: (2017)

Presence of anti-acetylated peptide antibodies (AAPA) in inflammatory arthritis and other rheumatic diseases suggests discriminative diagnostic capacity towards early rheumatoid arthritis
por: Studenic, Paul, et al.
Publicado: (2021)

Autoantibodies in rheumatoid arthritis and their clinical significance
por: Steiner, Günter, et al.
Publicado: (2002)

Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind?
por: Aletaha, Daniel
Publicado: (2006)

Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor
por: Tan, Eng M., et al.
Publicado: (2016)

Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data
por: Dougados, M, et al.
Publicado: (2008)

Role of clinical and biochemical inflammation in structural progression of patients with psoriatic arthritis
por: Borst, Carina, et al.
Publicado: (2021)

Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis
por: Aletaha, Daniel, et al.
Publicado: (2019)

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
por: Stoffer, Michaela A, et al.
Publicado: (2016)

Effects of a brief workplace-centered consultation for employees with musculoskeletal pain on health outcomes: a prospective cohort study
por: Leiss, Harald, et al.
Publicado: (2019)

Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial
por: Stamm, Tanja Alexandra, et al.
Publicado: (2018)

I do not want to suppress the natural process of inflammation: new insights on factors associated with non-adherence in rheumatoid arthritis
por: Ritschl, Valentin, et al.
Publicado: (2018)

Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project
por: Stoffer, Michaela A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pvnb9fgrgthujfbdv7lrqaejnv